Expression of concern
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Paper Information
Record ID:
35387
Author(s):
Publication Date:
June 21, 2021
Retraction Date:
February 07, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
- Evidence-based Medicine Consultancy, Bath, United Kingdom
- Emergency Department, Princess Elizabeth Hospital, Guernsey, United Kingdom
- Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, Northern Ireland, United Kingdom
Country:
🇬🇧 United KingdomArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1097/CND.0000000000000400Citations (236)
236
Total Citations160
Post-Retraction(67.8%)
76
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
11
Within 30 days
104
Within 1 year
28
After 2+ years
1234
Days since retraction (latest)
Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles
Martin Tobi, Diptaraj Chaudhari, Elizabeth P. Ryan et al. (11 authors)
Biomolecules
Open Access
Published: Jun 2025
1234 days after retraction
Ivermectin repurposing for COVID-19: pharmacological and bibliometric analysis
Mira Dulle, Roland Seifert
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: May 2025
1184 days after retraction
Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole
Shakta Mani Satyam, Mohamed El‐Tanani, Mohamed Anas Patni et al. (10 authors)
Antibiotics
Open Access
Published: Apr 2025
1 citation
1 citation
1178 days after retraction
Systematic Reviewers Have an Obligation to Promote Research Integrity
Lisa Bero
The Journal of Law Medicine & Ethics
Published: Apr 2025
1162 days after retraction
Development and Optimization of Lyophilized Dry Emulsion Tablet for Improved Oral Delivery of Ivermectin
Eiman Abdalla Madawi, Hanan M. El-Laithy, Nihal Mohamed Elmahdy Elsayyad et al. (6 authors)
Journal of Drug Delivery Science and Technology
Published: Apr 2025
1149 days after retraction
Novel progression on clinical therapy of COVID-19: Western and Traditional Chinese Medicines
Yongjia Xiong, Yun Li, Feiyue Xing
Unknown Journal
Open Access
Published: Mar 2025
1143 days after retraction
Paper citing Ivermectin for Prevention and Treatment of COVID-1...
Unknown Authors
Unknown Journal
Published: Mar 2025
1118 days after retraction
Experimental Investigation into the Design, Optimization, Toxicity, and Anti-Viral Efficacy of Proliposomes Loaded with Ivermectin Against Infectious Bronchitis Virus Using an Embryonated Chicken Egg Model
Mohammad H. Alyami, Hamad S. Alyami, Asmaa M. Abdo et al. (7 authors)
Pharmaceutics
Open Access
Published: Jan 2025
1083 days after retraction
The Ivermectin Related Compound Moxidectin Can Target Apicomplexan Importin α and Limit Growth of Malarial Parasites
Sujata B. Walunj, Geetanjali Mishra, Kylie M. Wagstaff et al. (5 authors)
Cells
Open Access
Published: Jan 2025
1060 days after retraction
Ivermectin as a Treatment Modality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Up-To-Date RCTs
Raghava Kalyan Maddukuri, Madhavi Latha Desimalla, Reshma Banavathu et al. (4 authors)
Indian Journal of Community Medicine
Open Access
Published: Jan 2025
1059 days after retraction
Medical Ethics and Informed Consent to Treatment: Past, Present and Future
Alan Mordue, Elizabeth Evans, J Royle et al. (4 authors)
Cureus
Open Access
Published: Dec 2024
1036 days after retraction
Clinical Experience With Ivermectin and Nitazoxanide in the Management of COVID-19 Among Mexican Out- and Inpatients
Jorge García-Méndez, Luis E. Fernández-Garza, Karen Vallejo-Oviedo et al. (10 authors)
Cureus
Open Access
Published: Nov 2024
1023 days after retraction
The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis
Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty et al. (9 authors)
International Journal of Biological Macromolecules
Published: Nov 2024
11 citations
11 citations
998 days after retraction
Repositioning of Antibiotics in the Treatment of Viral Infections
Anaíd Bustos-Hamdan, Jair Isidoro Bracho-Gallardo, Aída Hamdan-Partida et al. (4 authors)
Current Microbiology
Open Access
Published: Oct 2024
2 citations
2 citations
992 days after retraction
Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2
Sunil J. Wimalawansa
Biology
Open Access
Published: Oct 2024
4 citations
4 citations
982 days after retraction
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials
Nathália Mariana Santos Sansone, Matheus Negri Boschiero, Fernando Augusto Lima Marson
Biomedicines
Open Access
Published: Sep 2024
10 citations
10 citations
963 days after retraction
Following the Science in the Age of COVID-19
Sander L. Gilman
Journal of Medical Humanities
Published: Sep 2024
954 days after retraction
COVID 19: Prevention and treatment through the Indian perspective
Harish Chandra, Archana Yadav, Rajendra Prasad et al. (12 authors)
Cytokine
Published: Sep 2024
1 citation
1 citation
951 days after retraction
Toxicologic Pathology Forum*: mRNA Vaccine Safety–Separating Fact From Fiction
Rani S. Sellers, Philip R. Dormitzer
Toxicologic Pathology
Published: Sep 2024
1 citation
1 citation
946 days after retraction
Repurposing Drugs to Treat Novel Infections: A Proposal for a Decision-Making Framework for Clinicians
Saroj Jayasinghe
Clinical Therapeutics
Published: Aug 2024
906 days after retraction
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
Ananda Wijewickrema, Hasini Banneheke, A. Pathmeswaran et al. (11 authors)
BMC Infectious Diseases
Open Access
Published: Jul 2024
2 citations
2 citations
896 days after retraction
HEALING PROTOCOLS AND TOXICOLOGY TESTS FOR SEQUELAE OF COVID‑19 INJECTABLES
Ki-Yeob Jeon
International Journal of Research -GRANTHAALAYAH
Published: Jul 2024
1 citation
1 citation
894 days after retraction
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity
Sunil J. Wimalawansa
Heliyon
Open Access
Published: Jul 2024
6 citations
6 citations
892 days after retraction
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
Chun-li Lu, Liuqing Yang, Xin-yan Jin et al. (21 authors)
Frontiers in Pharmacology
Open Access
Published: May 2024
1 citation
1 citation
840 days after retraction
The selective effect of Ivermectin on different human coronaviruses; in-vitro study
A. Shahin, Nofar Atari, Tal Meningher et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Apr 2024
1 citation
1 citation
801 days after retraction
Knowledge of non-communicable diseases and access to healthcare services among adults before and during COVID-19 pandemic in rural Tanzania
Nathanael Sirili, Manase Kilonzi, George Kiwango et al. (9 authors)
Frontiers in Public Health
Open Access
Published: Mar 2024
1 citation
1 citation
780 days after retraction
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis
Zhilong Song, Senyuan Shi, Yongli Zhang
Heliyon
Open Access
Published: Mar 2024
8 citations
8 citations
753 days after retraction
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George Α. Antoniou et al. (38 authors)
BMJ Open
Open Access
Published: Mar 2024
15 citations
15 citations
753 days after retraction
Potential therapeutic landscape of COVID-19: molecular targets, repurposed drugs, and nano- and cell-based intervention
Sarika Tomar, Priyanka Surya, R. Pandey et al. (5 authors)
Elsevier eBooks
Published: Jan 2024
1 citation
1 citation
693 days after retraction
Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand
Hiroshige Mikamo, Satoshi Takahashi, Yuka Yamagishi et al. (19 authors)
Journal of Infection and Chemotherapy
Published: Dec 2023
3 citations
3 citations
688 days after retraction
Lack of antiviral activity of probenecid <i>in vitro</i> and in Syrian golden hamsters
Helen Box, Joanne Sharp, Shaun H. Pennington et al. (25 authors)
Journal of Antimicrobial Chemotherapy
Open Access
Published: Nov 2023
3 citations
3 citations
654 days after retraction
Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
Acta Virologica
Open Access
Published: Nov 2023
3 citations
3 citations
633 days after retraction
Multiorgan failure from excessive polypharmacy self-medication with prescription and non-prescription drugs following SARS-CoV-2 infection: A case report
Kimberly Davis, Laura Ghiggino, Neda Hasan et al. (5 authors)
Clinical Infection in Practice
Open Access
Published: Oct 2023
1 citation
1 citation
627 days after retraction
The Detrimental Effect of Pre-Treatment with Ivermectin on Myocardial Ischemia
Sara Cheraghi, Shabnam Babataheri, Hamid Soraya
Pharmacology
Published: Oct 2023
625 days after retraction
Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph–Based Approach
Pei Lou, An Fang, Wanqing Zhao et al. (6 authors)
Journal of Medical Internet Research
Open Access
Published: Oct 2023
4 citations
4 citations
620 days after retraction
Ivermectin as a potential therapeutic strategy for glioma
Xing Hu, Yan Ju, Yue‐Kang Zhang
Journal of Neuroscience Research
Published: Oct 2023
2 citations
2 citations
610 days after retraction
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George Α. Antoniou et al. (38 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2023
5 citations
5 citations
595 days after retraction
Paper citing Ivermectin for Prevention and Treatment of COVID-1...
Unknown Authors
Unknown Journal
Published: Sep 2023
590 days after retraction
In-Hospital Receipt of Ivermectin Is Associated With No Benefit in Mortality, Disease Progression, or Length of Stay for Patients With Mild to Moderate COVID-19
Adam Hasse, Kimberly Korwek, Russell E. Poland
Infectious Diseases in Clinical Practice
Published: Sep 2023
571 days after retraction
Emergence of Pulmonary Tuberculosis While Recovering From COVID-19 Pneumonia: A Case Report
Bhanu Shrestha, Ravi Mahat
Cureus
Open Access
Published: Aug 2023
569 days after retraction
Total freedom in physical activity via body schema: being for itself and being in the world
Maria Kosma
Turkish Journal of Kinesiology
Open Access
Published: Aug 2023
3 citations
3 citations
566 days after retraction
Inhaled corticosteroids’ effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
Yasra Badi, Mohamed Hammad, Abdelrahman Tawfik et al. (9 authors)
Canadian Journal of Respiratory Therapy
Open Access
Published: Aug 2023
2 citations
2 citations
540 days after retraction
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J. Bijlsma et al. (11 authors)
BMJ Open Respiratory Research
Open Access
Published: Aug 2023
6 citations
6 citations
540 days after retraction
Potential Drugs in COVID-19 Management
Amin Gasmi, Sàdaf Noor, Alain Menzel et al. (11 authors)
Current Medicinal Chemistry
Published: Jul 2023
2 citations
2 citations
526 days after retraction
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data
Caitlin Bakker, Stephanie Boughton, Clóvis Mariano Faggion et al. (6 authors)
BMJ evidence-based medicine
Open Access
Published: Jul 2023
13 citations
13 citations
526 days after retraction
Incidence of scabies in Michigan during the COVID‐19 pandemic
Eric Olsen, Trilokraj Tejasvi, Mio Nakamura
JEADV Clinical Practice
Open Access
Published: Jun 2023
508 days after retraction
Explaining Why Africa had Much Lower COVID-19 Fatalities Per Million than Europe and North America
Alberto Boretti
Coronaviruses
Published: Jun 2023
479 days after retraction
Public Health Needs the Public Trust: A Pandemic Retrospective
Matthew Halma, Joshua Guetzkow
BioMed
Open Access
Published: May 2023
10 citations
10 citations
477 days after retraction
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Christof Plothe, Paul E. Marik et al. (4 authors)
Microorganisms
Open Access
Published: May 2023
12 citations
12 citations
464 days after retraction
Discontinuation of Antihypertensive Drug Use Compared to Continuation in COVID-19 Patients: A Systematic Review with Meta-analysis and Trial Sequential Analysis
Diego Chambergo‐Michilot, Fernando M. Runzer‐Colmenares, Pedro Segura-Saldaña
High Blood Pressure & Cardiovascular Prevention
Open Access
Published: May 2023
4 citations
4 citations
459 days after retraction
Quick Stats
Total Citations:
236
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025